Form D · Biotechnology
GLOBAL CELL SOLUTIONS INC
Charlottesville, VA · CIK 0001433877
Offering snapshot reported Jul 9, 2010 · SEC filing
- Reported sold
- $50K Offering amount: $50K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 28, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 9, 2010 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Aug 26, 2009 | Initial | $75,000 | No comparison | 3 | SEC filing |
| Apr 25, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144642
Source: Form D, filed Jul 9, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robin Felder | Director |
| Uday Gupta | Director, Executive |
| Jorg Pochert | Director |
| Ian Ratcliffe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
770 Harris Street Suite 104
Charlottesville, VA, 22903
Charlottesville, VA, 22903